49 research outputs found
IN3 COSTS ASSOCIATED WITH HCV AND RELATED COMPLICATIONS IN THE UNITED STATES FROM A MANAGED CARE PAYER'S PERSPECTIVE
Get PDFPHP42 CURRENT AND FUTURE USE OF PHARMACOECONOMIC AND OUTCOMES RESEARCH DATA IN DECISION-MAKING IN THE USA
Get PDF
Chemical Degradation of Intravenous Chemotherapy Agents and Opioids by a Novel Instrument
No full textPrivate Health Insurance And Risk Protection: Changes In Out-Of-Pocket Medical Spending, 2001 And 2005
No full textPCV94 ASSESSMENT OF THE STATUS OF HYPERTENSION MANAGEMENT IN NEWLY DIAGNOSED AND ESTABLISHED HYPERTENSION PATIENTS IN PRIMARY CARE PRACTICE
Get PDFPCV94 ASSESSMENT OF THE STATUS OF HYPERTENSION MANAGEMENT IN NEWLY DIAGNOSED AND ESTABLISHED HYPERTENSION PATIENTS IN PRIMARY CARE PRACTICE
No full textPCV2 EFFECTIVENESS OF MULTIPLE-MECHANISM ANTIHYPERTENSIVE MEDICATION: VALSARTAN-AMLODIPINE-HCTZ TRIPLE-THERAPY IN PRIMARY CARE
No full textReal-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
No full textPDB60 A Cost-Utility Analysis of Pregabalin Versus Duloxetine in Painful Diabetic Neuropathy
No full text
